Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages

Liang Cheng(First Affiliated Hospital of Anhui Medical University), Jiatao Liu(Anhui Medical University), Qingqing Liu(Anhui Medical University), Yu Liu(First Affiliated Hospital of Anhui Medical University), Lulu Fan(Anhui Medical University), Fang Wang(Anhui Medical University), Hanqing Yu(Anhui Medical University), Yuhuan Li(First Affiliated Hospital of Anhui Medical University), Lijia Bu(First Affiliated Hospital of Anhui Medical University), Xiaoqiu Li(First Affiliated Hospital of Anhui Medical University), Wei Wei(Anhui Medical University), Hua Wang(Anhui Medical University), Guoping Sun(First Affiliated Hospital of Anhui Medical University)
International Journal of Biological Sciences
January 1, 2017
Cited by 120Open Access
Full Text

Abstract

Immunosuppression is a significant factor in the progression of tumor invasion and metastasis. Melatonin, a well-known hormone, has certain cytotoxic and immune regulatory effects to inhibit tumor function. Exosomes are small membrane vesicles released by many kinds of cells, which contain different macromolecules, such as mRNAs and microRNAs (miRNAs), and proteins that can mediate communications between cells. Tumor-derived exosomes may cause immunosuppression, however, it is unknown whether melatonin can attenuate an immunosuppressive status by altering the function of tumor-derived exosomes. In the present study, we evaluated the effects of hepatocellularcarcinoma-derived exosomes (Exo-con) and exosomes derived from hepatocellularcarcinoma cells treated with 0.1 mM melatonin (Exo-MT), on the expression of inflammatory factors and programmed death ligand 1(PD-L1) by co-culturing Exo-con and Exo-MT, respectively, with macrophages differentiated from THP-1 cells or RAW264.7 cells. Our in vitro results indicate that Exo-MT can downregulate the expression of PD-L1 on macrophages while Exo-con can upregulate the expression of PD-L1 through flow cytometry and immunofluorescence analysis. In addition, Exo-con upregulates the secretion of cytokines, such as IL-6, IL-10, IL-1, and TNF- in macrophages. Accordingly, Exo-MT could attenuate the high expression of these inflammatory cytokines. Furthermore, in vivo experiments confirmed the results found in vitro. PD-L1 expression and cytokine secretion were lower in the Exo-MT group compared with those in the Exo-con group. Working to identify a specific mechanism, our research shows that Exo-MT decreases STAT3 activation compared to the Exo-con group. In summary, we found exosomes from melatonin treated hepatocellularcarcinoma cells alters the immunosupression status through STAT3 pathway in macrophages. Our study may provide a new avenue to investigate the mechanisms of melatonin in regulating an immunosuppressive status.


Related Papers

No related papers found

Powered by citation graph analysis